Microbio Co., Ltd. (4128.TWO)
TWD 22.5
(-4.86%)
TWD 22.5
(-4.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 603.88 Million TWD | -8.58% |
| 2022 | 970.14 Million TWD | -48.96% |
| 2021 | 1.9 Billion TWD | 9.35% |
| 2020 | 1.73 Billion TWD | 134.46% |
| 2019 | 741.38 Million TWD | 5.46% |
| 2018 | 703.02 Million TWD | -8.28% |
| 2017 | 766.48 Million TWD | -9.85% |
| 2016 | 850.25 Million TWD | -7.37% |
| 2015 | 917.85 Million TWD | -4.15% |
| 2014 | 957.59 Million TWD | 10.03% |
| 2013 | 870.29 Million TWD | -7.22% |
| 2012 | 938.04 Million TWD | -4.44% |
| 2011 | 981.65 Million TWD | 28.89% |
| 2010 | 761.62 Million TWD | 63.38% |
| 2009 | 466.16 Million TWD | 26.96% |
| 2008 | 367.16 Million TWD | 113.68% |
| 2007 | 171.83 Million TWD | 53.15% |
| 2006 | 112.2 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 189.82 Million TWD | -1.52% |
| 2024 Q2 | 251.82 Million TWD | -18.93% |
| 2023 Q3 | 286.79 Million TWD | -13.52% |
| 2023 Q2 | 331.64 Million TWD | 37.54% |
| 2023 Q1 | 241.12 Million TWD | -1.16% |
| 2023 FY | 886.89 Million TWD | -8.58% |
| 2023 Q4 | 192.75 Million TWD | -32.79% |
| 2022 Q1 | 251.58 Million TWD | -67.17% |
| 2022 Q2 | 208.64 Million TWD | -17.07% |
| 2022 Q3 | 265.97 Million TWD | 27.48% |
| 2022 Q4 | 243.95 Million TWD | -8.28% |
| 2022 FY | 970.14 Million TWD | -48.96% |
| 2021 Q4 | 766.3 Million TWD | 187.58% |
| 2021 Q1 | 233.56 Million TWD | -78.92% |
| 2021 FY | 1.9 Billion TWD | 9.35% |
| 2021 Q3 | 266.46 Million TWD | -58.0% |
| 2021 Q2 | 634.4 Million TWD | 171.62% |
| 2020 Q1 | 183.17 Million TWD | -11.11% |
| 2020 Q4 | 1.1 Billion TWD | 365.42% |
| 2020 Q2 | 209.04 Million TWD | 14.12% |
| 2020 Q3 | 238.05 Million TWD | 13.88% |
| 2020 FY | 1.73 Billion TWD | 134.46% |
| 2019 Q2 | 183.1 Million TWD | 11.3% |
| 2019 Q1 | 164.51 Million TWD | -19.14% |
| 2019 Q3 | 187.69 Million TWD | 2.51% |
| 2019 Q4 | 206.07 Million TWD | 9.79% |
| 2019 FY | 741.38 Million TWD | 5.46% |
| 2018 Q1 | 166.61 Million TWD | -0.37% |
| 2018 Q3 | 162.88 Million TWD | -4.23% |
| 2018 Q4 | 203.45 Million TWD | 24.91% |
| 2018 FY | 703.02 Million TWD | -8.28% |
| 2018 Q2 | 170.07 Million TWD | 2.08% |
| 2017 Q1 | 252.35 Million TWD | 20.49% |
| 2017 Q3 | 172.46 Million TWD | -1.13% |
| 2017 Q2 | 174.43 Million TWD | -30.88% |
| 2017 Q4 | 167.22 Million TWD | -3.04% |
| 2017 FY | 766.48 Million TWD | -9.85% |
| 2016 Q1 | 202.97 Million TWD | -6.76% |
| 2016 Q4 | 209.45 Million TWD | -0.89% |
| 2016 FY | 850.25 Million TWD | -7.37% |
| 2016 Q2 | 226.48 Million TWD | 11.58% |
| 2016 Q3 | 211.34 Million TWD | -6.69% |
| 2015 FY | 917.85 Million TWD | -4.15% |
| 2015 Q4 | 217.68 Million TWD | -8.19% |
| 2015 Q3 | 237.11 Million TWD | -2.45% |
| 2015 Q2 | 243.06 Million TWD | 10.49% |
| 2015 Q1 | 219.98 Million TWD | -10.84% |
| 2014 Q1 | 221.79 Million TWD | -3.21% |
| 2014 FY | 957.59 Million TWD | 10.03% |
| 2014 Q4 | 246.72 Million TWD | -5.55% |
| 2014 Q3 | 261.21 Million TWD | 14.64% |
| 2014 Q2 | 227.86 Million TWD | 2.74% |
| 2013 Q3 | 228.19 Million TWD | 7.5% |
| 2013 Q1 | 200.69 Million TWD | -4.83% |
| 2013 Q2 | 212.27 Million TWD | 5.77% |
| 2013 FY | 870.29 Million TWD | -7.22% |
| 2013 Q4 | 229.14 Million TWD | 0.42% |
| 2012 Q1 | 235.56 Million TWD | -1.32% |
| 2012 Q2 | 215.6 Million TWD | -8.47% |
| 2012 Q3 | 225.34 Million TWD | 4.51% |
| 2012 Q4 | 210.88 Million TWD | -6.41% |
| 2012 FY | 938.04 Million TWD | -4.44% |
| 2011 FY | 981.65 Million TWD | 28.89% |
| 2011 Q2 | 278.83 Million TWD | 12.56% |
| 2011 Q3 | 216.39 Million TWD | -22.39% |
| 2011 Q4 | 238.71 Million TWD | 10.31% |
| 2011 Q1 | 247.7 Million TWD | -1.38% |
| 2010 Q1 | 159.98 Million TWD | 0.0% |
| 2010 Q2 | 185.88 Million TWD | 16.18% |
| 2010 FY | 761.62 Million TWD | 63.38% |
| 2010 Q3 | 164.59 Million TWD | -11.45% |
| 2010 Q4 | 251.16 Million TWD | 52.6% |
| 2009 FY | 466.16 Million TWD | 26.96% |
| 2008 FY | 367.16 Million TWD | 113.68% |
| 2007 FY | 171.83 Million TWD | 53.15% |
| 2006 FY | 112.2 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Tehmag Foods Corporation | 942.4 Million TWD | 35.921% |
| SunWay Biotech Co., LTD. | 185.8 Million TWD | -225.007% |
| Hantech Bio-Technology Co., Ltd. | 95.14 Million TWD | -534.69% |
| Lian Fa International Dining Business Corp. | 288.61 Million TWD | -109.235% |
| Jia Jie Biomedical Co., Ltd. | 183.83 Million TWD | -228.491% |
| Chung Hwa Food Industrial Co., Ltd. | 294.65 Million TWD | -104.943% |
| DaBomb Protein Biotech Corp. | 76.35 Million TWD | -690.856% |
| Far East Bio-Tec Co., Ltd. | 113.69 Million TWD | -431.142% |
| We Can Medicines Co., Ltd. | 1 Billion TWD | 39.727% |
| Wonder Pets Enterprises Corporation | 940.2 Million TWD | 35.771% |
| Eagle Cold Storage Enterprise Co., Ltd. | 175.55 Million TWD | -243.986% |